India  

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Video Credit: HT Digital Content - Duration: 01:40s - Published
‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials.

The Congress leader raised questions over the efficacy of the indigenously developed Covaxin, which is in the third phase of trials and has been cleared for restricted emergency use by the Drugs Controller General of India.

‘Government should act in a manner whereby there's complete confidence in people.

You can't use rollout as phase 3 trial, Indians are not guinea pigs,’ Manish Tewari said.

The former minister’s remarks come after government hinted that people will not be allowed to choose from the two vaccines recently approved.

The first phase of coronavirus vaccination is all set to begin on 16th January, 2021.

Watch the full video for all the details.


You Might Like


💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

They thought they got the Covid-19 vaccine. They were part of a trial instead [Video]

They thought they got the Covid-19 vaccine. They were part of a trial instead

More than a dozen slum residents in Bhopal, India, say they thought they were being vaccinated for Covid-19. They say they later discovered from local activists that some of them hadn’t been given an approved vaccine and had unwittingly taken part in a Phase 3 clinical trial for India’s homegrown vaccine, Covaxin. CNN’s Vedika Sud reports.

Credit: Bleacher Report AOL    Duration: 03:42Published

Brazil to buy 20 million Covid-19 vaccines from India's Bharat Biotech

Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery..
IndiaTimes
"Covaxin is successful in tackling UK strain," informs ICMR [Video]

"Covaxin is successful in tackling UK strain," informs ICMR

Indian Council of Medical Research DG, Balram Bhargava announced that the Covaxin is successful in tackling UK strain. He further informed that UK variant strain is now present in 70 countries and 164 cases have been identified in India. "UK variant strain is now present in 70 countries and we've identified 164 cases of it in India. We were able to find the first case of the UK variant on 22nd-23rd December. In a week's time, we were able to collect blood from these patients and culture the strain. We found that the neutralisation of UK strain was equivalent to Indian strains circulating in India. It's a very reassuring news that UK variant can be tackled by this vaccine," informed ICMR DG during a press briefing on January 28.

Credit: ANI    Duration: 01:55Published

Manish Tewari Manish Tewari Indian politician

It's against informed consent: Manish Tewari on people won't be able to choose vaccine [Video]

It's against informed consent: Manish Tewari on people won't be able to choose vaccine

Indian National Congress spokesperson Manish Tewari raised questions on COVAXIN's efficacy. He said, "Many eminent doctors have raised questions with regard to the efficacy and safety of COVAXIN with government saying that people will not be able to choose as to which vaccine they would like to take. This goes against the entire doctrine of informed consent." "If the vaccine is so safe and reliable and efficacy of the vaccine is beyond question then how is it that not a single functionary of the government has stepped forward to get themselves vaccinated as it has happened in other countries around the world?," he said.

Credit: ANI    Duration: 02:32Published
Indians are not guinea pigs: Manish Tewari on rollout of Covaxin [Video]

Indians are not guinea pigs: Manish Tewari on rollout of Covaxin

Congress MP Manish Tewari raised objection on the rollout of Covaxin. Manish Tewari said that government should either not roll out Covaxin till its efficacy and reliability is completely established or phase 3 trials are not over. He further said that Indians are not guinea pigs. "Covaxin was licensed by Government for emergency use. Now Government is saying that the recipient won't be able to pick and choose the vaccine which he's administered to. When phase 3 trials of Covaxin are not complete, it raises various concerns on its efficacy. Either government shouldn't roll out Covaxin till its efficacy and reliability is completely established and phase 3 trials are over. It should act in a manner whereby there's complete confidence in people. You can't use rollout as phase 3 trial, Indians are not guinea pigs," said Manish Tewari.

Credit: ANI    Duration: 01:10Published

United States Congress United States Congress Legislature of the United States

Congress getting weaker by the day: ‘G-23’ leaders

The Congress ‘G-23’ bloc of dissenting leaders said at a public rally in Jammu on Saturday the party was weakening by the day and it was their endeavour to..
IndiaTimes

Assam Assembly Election 2021: RJD to contest polls, looking at forming alliance with other parties, says Tejashwi Yadav

"We discussed with Congress about an alliance. We will also be speaking to All India United Democratic Front (AIUDF) Chief Ajmal Sahab," he said.
DNA
With old clips of Modi, Congress shows BJP's 'hypocrisy' over rising fuel prices [Video]

With old clips of Modi, Congress shows BJP's 'hypocrisy' over rising fuel prices

Building pressure on the central government over the rising fuel prices, the Congress on February 27, during a press briefing, showed old clips of Prime Minister Narendra Modi, then Gujarat Chief Minister, criticising the then Congress government over skyrocketing petroleum prices. Congress national spokesperson reminded BJP of its hypocrisy over rising fuel prices, and urged the Modi government to revoke recent hikes in the fuel prices.

Credit: ANI    Duration: 02:00Published

Indian people Indian people Nationals or citizens of India

MEA advises Indians in Canada to report threat calls to embassy, local police [Video]

MEA advises Indians in Canada to report threat calls to embassy, local police

Indian nationals in Canada received threat calls from pro-Khalistani groups for their 'tiranga rally' in support of farm laws. Ministry of External Affairs spokesperson Anurag Srivastava said that the issue has been taken up with Canadian authorities both in Ottawa and Delhi. MEA spokesperson advised Indian nationals to report any such incidents to local police and Indian High Commission and consultants in Canada. "We have come across reports of threats and intimidation to some members of the Indian community in Canada. We have requested Canadian authorities to take steps to ensure the safety of Indian nationals in Canada," Anurag Srivastava added.

Credit: ANI    Duration: 01:00Published
Indians working in Gulf countries have full support of Centre to ensure their welfare: PM Modi [Video]

Indians working in Gulf countries have full support of Centre to ensure their welfare: PM Modi

Prime Minister Narendra Modi on February 14 said that Indians working in Gulf countries have full support of the government it is there to ensure their welfare. PM Modi inaugurated and laid the foundation stones of several projects in Kochi.

Credit: ANI    Duration: 01:47Published

Drugs Controller General of India

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human..
IndiaTimes
Explained: India announces Covid vaccination launch date; who's first in line? [Video]

Explained: India announces Covid vaccination launch date; who's first in line?

The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had cleared 2 vaccines - Covaxin and Covishield - for emergency use. Covaxin, made by Bharat Biotech, will be used under clinical trial conditions, as per the government. Covishield was developed by Oxford university and pharma major AstraZeneca, and is being made in India by Serum Institute of India (SII). Around 30 crore people are being targeted for vaccination in phase 1. These include healthcare staff, frontline workers like police, those aged above 50, and those aged below 50 but with co-morbidities. Watch the full video for more.

Credit: HT Digital Content    Duration: 01:34Published

Related videos from verified sources

Tamil Nadu health minister gets Covaxin shot, says ‘let’s end Covid together’ [Video]

Tamil Nadu health minister gets Covaxin shot, says ‘let’s end Covid together’

Tamil Nadu health minister C Vijayabaskar voluntarily took the vaccine Covaxin at Rajiv Gandhi Government General Hospital in Chennai. Vijayabaskar, who is a doctor and a member of the IMA, had earlier..

Credit: HT Digital Content     Duration: 02:14Published
‘Covid vaccines safe; politics on issue is unfortunate’: Health Minister [Video]

‘Covid vaccines safe; politics on issue is unfortunate’: Health Minister

Union Health minister Dr. Harsh Vardhan reiterated the two vaccines which have been granted approval for use in India are safe and effective. He added that some people are playing politics over the..

Credit: HT Digital Content     Duration: 03:11Published
India launches world's largest vaccination drive [Video]

India launches world's largest vaccination drive

India on Saturday (January 16) launched the world's largest vaccination drive after receiving millions of doses of two approved vaccines - Covishield and Covaxin.

Credit: Newsflare STUDIO     Duration: 02:05Published